Synthesis and In Silico Evaluation of Some New 2,4-Disubstituted Thiazole Derivatives
European Journal of Life Sciences · 2022
DOI: 10.55971/ejls.1089425 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Life Sciences, 2022. Verfasst von Leyla Yurttaş und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
The synthesis and antiproliferative activity investigation of methyl 3/4-[[4-(2-substituted thiazol-4-yl)phenyl]amino]-3-oxopropanoate/(4-oxobutanoate) (3a-h) derivatives were aimed in this work. The synthesis of the new compounds were carried out by a simple, multiple-step synthetic procedure. The physicochemical properties of the compounds were determined using SwissADME and QuickProp software systems. Additionally, virtual target and toxicity predictions were carried out for all final compounds. The pharmacokinetics/physicochemical, druglikeness properties and biological target and toxicity predicitions of the compounds were determined to possess satisfying findings. Since the target determination of the compounds according to literature is point out their cytotoxic properties, the DNA gyrase enzyme was chosen as common enzymatic pathway, and evaluated via docking studies. Compound 3b, namely methyl 4-[[4-(2-methylthiazol-4-yl)phenyl]amino]-4-oxobutanoate was detected to possess a potential to inhibit DNA gyrase-ATPase activity.
Zitieren
APA
Yurttaş, L., Evren, A. E., & Özkay, Y. (2022). Synthesis and In Silico Evaluation of Some New 2,4-Disubstituted Thiazole Derivatives. European Journal of Life Sciences. https://doi.org/10.55971/ejls.1089425
Vancouver
Yurttaş L, Evren AE, Özkay Y. Synthesis and In Silico Evaluation of Some New 2,4-Disubstituted Thiazole Derivatives. European Journal of Life Sciences. 2022. doi:10.55971/ejls.1089425
BibTeX
@article{Yurtta2022,
author = {Yurttaş, Leyla and Evren, Asaf Evrim and Özkay, Yusuf},
title = {Synthesis and In Silico Evaluation of Some New 2,4-Disubstituted Thiazole Derivatives},
journal = {European Journal of Life Sciences},
year = {2022},
doi = {10.55971/ejls.1089425}
}
EUVIMED